MDA provides more support to ALS patients than any other nonprofit group. Since its inception in 1950, MDA has dedicated almost $325 million to ALS research, health care services, advocacy and information programs.
MDA currently is funding 50 ALS research projects worldwide, with a total commitment of $15 million. Our nationwide network of nearly 200 specialized neuromuscular disease clinics — including 44 designated ALS centers — is the largest in the country and is staffed by top health professionals skilled in the diagnosis and medical management of ALS.
We make legislators and policymakers aware of issues of importance to our community in matters of public policy, research advances, and therapy development and regulation. And people affected by ALS count on MDA for information about what matters most: diagnosis, signs and symptoms, medical management, research, clinical trials, health care services and support, and daily living strategies.
No one does more to fight ALS than MDA.
We invite you to learn more on MDA’s website:
ALS Disease Center.
In amyotrophic lateral sclerosis (ALS), nerve cells called motor neurons inexplicably die, leading to weakness and eventual paralysis of all voluntary muscles, including those used for breathing and swallowing. There is no cure, and death often occurs within five years of an ALS diagnosis, although some people live for decades with the disease.
For more information about ALS, please visit MDA’s ALS disease information center.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.